01—Abstract
Summary
Summary of the 8-K filed March 5, 2026. Cited figures are marked; the original filing is the authoritative source.
McKesson (NYSE: MCK) announced in an 8-K filed March 5, 2026 that CFO Britt Vitalone will retire.
His last day as CFO is May 28, 2026, he remains an employee through July 1, 2026, and then becomes a non-employee advisor at a $50,000a monthly fee under an Advisor Agreement effective July 2, 2026. Kenny K. Cheung, most recently CFO of Sysco and previously CFO of Hertz, will succeed him as EVP and CFO effective May 29, 2026.
The one-day gap between Vitalone's last day and Cheung's start date is a minor transition detail to note. Cheung's pay package is substantial: a $3.5 millionb sign-on bonus (subject to prorated clawback if he leaves before the second anniversary of hire), $6.0 million in sign-on RSUs, a $1.05 million base salary, a 125% target bonus under the Management Incentive Plan, and ongoing equity of $3.45 million in FY2027–2029 PSUs and $2.3 million in RSUs. The sign-on and annual equity grants are typical for a senior CFO hire at this scale and signal the company's intent to secure experienced finance leadership, though the filing itself does not comment on performance expectations.
The press release frames the transition as orderly. Management credits Vitalone with financial discipline, capital allocation, and shareholder engagement, and notes his continued role as a strategic advisor during the planned separation of the Medical Surgical Solutions segment.
The release also highlights record third-quarter revenue and adjusted operating profit, driven by oncology, multispecialty, and biopharma services and core distribution. Investors should watch how the separation of Medical Surgical Solutions is executed under new finance leadership.
02—Key points
Key Highlights
- CFO Britt Vitalone, who has served more than eight years as CFO and 20 years with the company, will retire; his last day as CFO is May 28, 2026.
- Kenny K. Cheung, age 44, joins as EVP and CFO effective May 29, 2026, coming from Sysco where he was EVP and CFO since 2023, and previously CFO of Hertz (2020–2023), where he helped guide the company through Chapter 11.
- Cheung's compensation includes a $3.5M sign-on bonus, $6.0M in sign-on RSUs, a $1.05M base salary, a 125% target bonus opportunity, and annual equity of $3.45M in PSUs (FY2027–2029) and $2.3M in RSUs.
- Vitalone transitions to a non-employee advisor under an Advisor Agreement effective July 2, 2026, paid $50,000 per month plus expense reimbursement, with no other compensation or benefits.
- Management attributes the transition to a planned process supporting the separation of the Medical Surgical Solutions segment into an independent company.
- The company reported record third-quarter revenue and record adjusted operating profit, with strength in oncology, multispecialty and biopharma services, and core distribution.
- Vitalone's advisory role is expected to support continuity through the Medical Surgical Solutions separation.
03—Questions
Frequently Asked Questions
Why is McKesson's CFO leaving?
Britt Vitalone elected to retire after a 20-year career at McKesson, including more than eight years as CFO. The company describes the retirement as a planned transition and says he will remain involved as a strategic advisor.
Who is replacing the CFO and what is his background?
Kenny K. Cheung, 44, will become EVP and CFO effective May 29, 2026. He is currently EVP and CFO of Sysco (since 2023), and previously served as CFO of The Hertz Corporation from 2020 to 2023, where he oversaw global finance and helped guide the company through its Chapter 11 restructuring.
What is the cost of the CFO transition for McKesson?
The filing discloses Cheung's one-time sign-on package of a $3.5M bonus and $6.0M in RSUs, plus annual compensation of a $1.05M base salary and $5.75M in target annual equity grants. Vitalone's advisory fee is $50,000 per month. The filing does not disclose the total cost or any severance terms for Vitalone.
Is there a gap in the CFO handover?
Vitalone's last day as CFO is May 28, 2026, and Cheung's appointment is effective May 29, 2026, so the handover is effectively immediate. Vitalone remains an employee through July 1, 2026, and then serves as an independent contractor advisor from July 2, 2026.
Does this transition affect McKesson's financial outlook?
The filing and press release do not change guidance or financial outlook. Management highlights record Q3 results and strong momentum across its segments. The main investor focus will be on continuity of financial execution and the planned separation of the Medical Surgical Solutions segment under new finance leadership.
04—Continue